Physician profile
Wesley Warton Mitchell
NPI 1972955276
$883.96
in general payments reported to CMS, 2019-2025
20 companies · $97.61 in 2025
The $97.61 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $177 · 2022: $91.58 · 2023: $246 · 2024: $272 · 2025: $97.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $144.88 | 2024 | Nvm5 |
| Relievant Medsystems, INC. | $116.29 | 2021 | |
| Depuy Synthes Sales INC. | $86.42 | 2023-2024 | Orthovisc, Monovisc, Symphony |
| Providence Medical Technology, INC. | $76.20 | 2023 | |
| Aesculap, INC. | $56.04 | 2023 | Elan 4 |
| Peerless Surgical INC. | $45.66 | 2023 | |
| Ermi LLC | $43.71 | 2022 | |
| Stryker Corporation | $43.69 | 2021-2022 | |
| Medtronic, INC. | $36.92 | 2022-2025 | Inceptiv |
| Cerapedics INC. | $31.11 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Bioventus LLC | $30.69 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $26.78 | 2025 | |
| Heron Therapeutics, INC. | $22.83 | 2024 | Zynrelef |
| Boston Scientific Corporation | $22.21 | 2024 | |
| Smith+Nephew, INC. | $22.11 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18.50 | 2025 | Airsupra |
| Solventum Corporation | $16.38 | 2025 | Prevena |
| Pacira Pharmaceuticals Incorporated | $15.03 | 2023 | Zilretta, Iovera, Exparel |
| Integra Lifesciences Corporation | $14.71 | 2022 | |
| Innovation Technologies INC | $13.80 | 2025 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.